Key facts
- Notable investors include New Harbor Capital, Avante Capital Partners, Capital Southwest.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Monroe Biomedical Research
- ·The full record, as it builds
Funding rounds
No funding rounds for Monroe Biomedical Research are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Monroe Biomedical Research
Operator of a private clinical trial facility focused on recruiting patient populations for complex clinical trials across a broad spectrum of therapeutic areas. The company engages in a wide range of clinical trials, including investigations into treatments for pulmonary, metabolic, cardiological, psychiatric and infectious diseases, as well as vaccine studies.
- Sector
- Healthcare
- HQ
- Monroe, NC, United States
- Founded
- 2014
- Employees
- 46
- Website
- monroeresearch.com/
- Ownership
- Privately Held (backing)
Monroe Biomedical Research doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Monroe Biomedical Research shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Monroe Biomedical Research in its N-PORT filings yet. We sweep new filings monthly.